Bosticardo Gianmario, Malberti Fabio, Basile Carlo, Leardini Loretta, Libutti Pasquale, Filiberti Oliviero, Schillaci Enrico, Ravani Pietro
Hospital-Territory Department, Nephrology and Dialysis Unit, Ospedale degli Infermi, Biella, Italy.
Nephrol Dial Transplant. 2012 Jun;27(6):2489-96. doi: 10.1093/ndt/gfr733. Epub 2012 Feb 21.
There is no consensus regarding the optimal dialysate calcium concentration (DCa) during haemodialysis (HD). Low DCa may predispose to acute arrhythmias, whereas high DCa increases the long-term risk of soft tissue calcifications.
Twenty-two HD patients treated in four dialysis centres underwent two HD sessions, respectively, with 1.5 and 1.25 mmol/L total DCa. Calcium mass balance (CMB) was calculated from ionized calcium (iCa) in the dialysate and blood at the start and end of each run, using a kinetic formula to define the mean concentrations in the blood and dialysate and then estimating CMBs over the entire treatments.
Mean blood iCa levels increased using 1.5 DCa, whereas they remained unchanged using 1.25 DCa. Diffusive CMB positively correlated with the dialysate/blood iCa gradient. With 1.5 DCa, diffusive CMBs were strongly positive at the blood side and negative at the dialysate side, indicating transfer from dialysate to blood. With 1.25 DCa, despite a negative dialysate/blood iCa gradient, diffusive CMB was slightly positive in blood and negative in dialysate. The global balances based on both the convective and diffusive components showed a positive net transfer of Ca from dialysate to blood with 1.5 DCa and an approximately neutral Ca flux with 1.25 DCa.
While CMB is nearly neutral when using 1.25 DCa, the use of 1.5 DCa results in a gain of Ca during HD. The risks associated with Ca load should be considered in the choice of DCa prescription for HD but need also be weighed against the risk of worse haemodynamic dialysis tolerance.
关于血液透析(HD)期间的最佳透析液钙浓度(DCa)尚无共识。低DCa可能易引发急性心律失常,而高DCa会增加软组织钙化的长期风险。
在四个透析中心接受治疗的22例HD患者分别进行了两次HD治疗,总DCa分别为1.5和1.25 mmol/L。根据每次治疗开始和结束时透析液和血液中的离子钙(iCa)计算钙质量平衡(CMB),使用动力学公式定义血液和透析液中的平均浓度,然后估算整个治疗过程中的CMB。
使用1.5 DCa时平均血液iCa水平升高,而使用1.25 DCa时保持不变。扩散性CMB与透析液/血液iCa梯度呈正相关。使用1.5 DCa时,血液侧的扩散性CMB为强阳性,透析液侧为阴性,表明从透析液向血液转移。使用1.25 DCa时,尽管透析液/血液iCa梯度为负,但血液中的扩散性CMB略为阳性,透析液中为阴性。基于对流和扩散成分的总体平衡显示,使用1.5 DCa时Ca从透析液向血液有正向净转移,使用1.25 DCa时Ca通量近似为中性。
使用1.25 DCa时CMB几乎为中性,而使用1.5 DCa时在HD期间会导致Ca增加。在选择HD的DCa处方时应考虑与Ca负荷相关 的风险,但也需要权衡较差的血液动力学透析耐受性风险。